Published in Int J Alzheimers Dis on September 12, 2011
Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet (2013) 0.96
Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. Int J Cell Biol (2012) 0.96
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Adv Pharmacol (2012) 0.89
Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg Neurol Int (2012) 0.86
The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age. Front Hum Neurosci (2013) 0.86
Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity. Int J Alzheimers Dis (2012) 0.80
Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid. J Aging Res (2013) 0.80
Genome-wide imaging association study implicates functional activity and glial homeostasis of the caudate in smoking addiction. BMC Genomics (2017) 0.75
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell (2005) 8.40
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell (2004) 7.45
Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol (1990) 5.60
Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech (1994) 5.34
The axonal transport of mitochondria. J Cell Sci (2005) 5.19
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet (2006) 3.94
2010 Alzheimer's disease facts and figures. Alzheimers Dement (2010) 3.73
Mitochondria in neuroplasticity and neurological disorders. Neuron (2008) 3.35
Classification and basic pathology of Alzheimer disease. Acta Neuropathol (2009) 3.24
Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci (1998) 3.03
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med (2008) 2.74
The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest (2005) 2.51
The pathogenesis of senile plaques. J Neuropathol Exp Neurol (1997) 2.49
Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol (2003) 2.32
Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci (1993) 2.09
Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res (2010) 2.07
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis (2001) 2.02
Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria. J Biol Chem (2006) 1.93
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci (2005) 1.83
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging (2000) 1.78
Cajal-Retzius cells and the development of the neocortex. Trends Neurosci (1998) 1.73
Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta (1998) 1.71
Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis (2006) 1.65
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41
Mechanisms of mitochondria-neurofilament interactions. J Neurosci (2003) 1.41
Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim Biophys Acta (2011) 1.37
Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging (2004) 1.30
The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol (2002) 1.29
Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc Natl Acad Sci U S A (1997) 1.26
Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. Proc Natl Acad Sci U S A (2011) 1.22
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis (2006) 1.20
Interactions between brain mitochondria and cytoskeleton: evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Tech (1994) 1.13
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta (1995) 1.07
Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res (2002) 1.07
Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep (2001) 1.06
The key role of mitochondria in Alzheimer's disease. J Alzheimers Dis (2006) 1.05
Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions. Exp Gerontol (2000) 1.05
A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J Clin Invest (1999) 1.03
Disassembly of actin filaments leads to increased rate and frequency of mitochondrial movement along microtubules. Cell Motil Cytoskeleton (1998) 1.03
Cytoskeletal-assisted dynamics of the mitochondrial reticulum in living cells. Proc Natl Acad Sci U S A (2002) 1.02
Mitochondrial alterations in Alzheimer's disease. Am J Alzheimers Dis Other Demen (2004) 1.00
Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem (2000) 0.98
Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res (2002) 0.98
Three-dimensional structural organization of layer I of the human cerebral cortex: a Golgi study. J Comp Neurol (1990) 0.95
Transport of proteins into mitochondria. Rev Physiol Biochem Pharmacol (2001) 0.88
Review. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol (1996) 0.88
Synaptic alterations in the vestibulocerebellar system in Alzheimer's disease--a Golgi and electron microscope study. Acta Otolaryngol (2000) 0.87
Altered mitochondrial membrane fluidity in AD brain. Neurosci Lett (1996) 0.85
beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. Exp Neurol (2002) 0.85
Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol Dis (1999) 0.84
The vestibulo-ocular response during transient arousal shifts in man. Acta Otolaryngol (1992) 0.83
Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab Rev (1999) 0.82
The acoustic cortex in Alzheimer's disease. Acta Otolaryngol Suppl (1992) 0.80
Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol Disord Drug Targets (2011) 0.78
Genetics of neurodegenerative disorders. N Engl J Med (2003) 0.77